AgaMatrix is a consumer medical device company that develops and manufactures blood glucose monitoring (BGM) products for the diabetes market. Products are based on the company's proprietary WaveSenseÔ biosensor platform, which consists of a suite of patent-pending test strip, dynamic electrochemistry, digital signal processing, and lancing technologies. FDA approval and first revenue was achieved in early 2006, and a steep growth path is expected. AgaMatrix intend to use its proprietary technology to make a significant and positive impact on the diagnostic device and disposables industry.
